Neurovascular manifestations of connective-tissue diseases: a review

ST Kim, W Brinjikji, G Lanzino… - Interventional …, 2016 - journals.sagepub.com
Patients with connective tissue diseases are thought to be at a higher risk for a number of
cerebrovascular diseases such as intracranial aneurysms, dissections, and acute ischemic …

Insights into novel choroidal and retinal clinical signs in neurofibromatosis type 1

F Mallone, L Alisi, L Lucchino, V Di Martino… - International Journal of …, 2023 - mdpi.com
Neurofibromatosis type 1 (NF1) is a rare inherited neurocutaneous disorder with a major
impact on the skin, nervous system and eyes. The ocular diagnostic hallmarks of this …

[HTML][HTML] Western moyamoya phenotype: a scoping review

R Miller, SR Unda, R Holland, DJ Altschul - Cureus, 2021 - ncbi.nlm.nih.gov
Moyamoya, a rare angiographic finding, is characterized by chronic and progressive
stenosis at the terminal end of the internal carotid artery, followed by collateralization of the …

Surgery for moyamoya disease in children

R Appireddy, M Ranjan, BA Durafourt… - Journal of Child …, 2019 - journals.sagepub.com
Moyamoya disease is a chronic progressive cerebrovascular occlusive disease of the
terminal portion of the internal carotid arteries associated with an acquired abnormal …

Imaging Review of Pediatric Monogenic CNS Vasculopathy with Genetic Correlation

N Gupta, E Miller, A Bhatia, J Richer, RI Aviv… - RadioGraphics, 2024 - pubs.rsna.org
Monogenic cerebral vasculopathy is a rare but progressively recognizable cause of pediatric
cerebral vasculopathy manifesting as early as fetal life. These monogenic cerebral …

Spinal muscular atrophy type IIIb complicated by Moyamoya syndrome: a case report and literature review

J Li, X Li, L Wang, G Wu - Frontiers in Cellular Neuroscience, 2022 - frontiersin.org
Spinal muscular atrophy (SMA) is an inherited disorder characterized by degeneration of
motor neurons and symmetrical muscle weakness and atrophy. Moyamoya syndrome …

Vascular Abnormalities and Neurofibromatosis Type 1: A Paediatric Case Series

P Currao, M Balzarini, D Pruna… - Journal of Child …, 2025 - journals.sagepub.com
Neurofibromatosis type 1 (NF1) is a multisystemic neurocutaneous disease caused by a
heterozygous mutation of the NF1 gene that encodes neurofibromin. Complications include …

Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome

A D'Amico, L Ugga, S Cocozza, SMA Giorgio… - Neurological …, 2021 - Springer
Purpose Moyamoya syndrome (MMS) is a rare intracranial arterial vasculopathy which can
occur in neurofibromatosis type 1 (NF1) disease, representing a cause of cerebrovascular …

Cerebral Arteriopathies of Childhood–Current Approaches

D Davila-Williams, M Barry, C Vargas… - Seminars in pediatric …, 2022 - Elsevier
Up to more than half of previously healthy children presenting with their first arterial ischemic
stroke have a cerebral arteriopathy. Cerebral arteriopathies during childhood can be …

[PDF][PDF] Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature

M Budişteanu, CM Burloiu, SM Papuc… - Rom J Morphol …, 2019 - researchgate.net
Abstract Neurofibromatosis type 1 (NF1) is a genetic disorder with a very heterogeneous
clinical picture, affecting central nervous system, skin and bone system. Cerebrovascular …